Displayng his 2 stickers after casting ballot.
By the end of this calendar year’s first quarter (January-March), I can realistically state that I helped Fresenius Medical Care, the largest dialysis-related conglomerate in the entire world, to increase one of its numbers in a May 3-released financial report reflecting its U.S. and international operations.
I really can’t get too excited, though, about my part in the report. After reading that the Marion County voting turnout (16 percent of those who are registered) was low, I still believe my effort on the political front was more impactful than my contribution was to the Fresenius divulgement.
For those who may have followed my medical concerns, you may recall I went on dialysis a year ago February, and since have documented the journey in my book titled Dialing in on DIAL-Y-SIS. Since that writing, I have shifted my weekly treatments from an independent clinic to a spanking-new center, Fresenius Kidney Care Southport. That transition this past February placed me right in the middle of its parent-company’s financial report.
So, really what was my contribution to this latest Fresenius financial disclosure?
According to this recent report, the company – by the end of March (2018) – was treating 197,339 patients at its 2,419 clinics in North America. The report also documented a 4 percent increase in treatment numbers. Without my contribution, the number of patients would have tallied only 197,338. How about that on my part?
The report also indicated the company increased 4 percent in its number of clinics. While my Fresenius Southport treatment center opened only full-fledge at the start of this calendar year, I did join the Indianapolis Southside clinic in February, being among the first dozen patients at the new 24-chair facility. During the past several weeks, the Southport in-center numbers are increasing by a new patient every day or so. Eventually, the clinic will accommodate more than 70 patients calling the facility their treatment home on three days of each, and every, week.
Being a national and international player in the dialysis industry, it is not surprising that Fresenius is noted to have a major stake in Central Indiana. In Marion County and the eight surrounding counties, Fresenius operates nearly 20 in-center clinics with around 330 chairs providing more than 3,000 treatments a week.
In the Central Indiana area, there are about 40 in-center dialysis clinics that push the total number of in-center dialysis treatments likely to roughly double (6,000 weekly treatments).
In my Dialing in on DI-AL-Y-SIS book (promoted on www.diodialysis.com), I point out the enormity of the dialysis industry. Two mega companies – Fresenius Medical Care, based in the United States at Waltham (Massachusetts), and DaVita, located in Denver (Colorado) – dominate the landscape. Between the two, they operate more than 4,500 treatment facilities, with more than 350,000 patients.
For the year 2015, Fresenius netted more than $1 billion (that’s dollars, now) in after-tax profit; for that same year, DaVita’s net patient revenue was $668 million. Over 90 percent of the machines utilized in the provision of hemodialysis are manufactured by Fresenius, with well over 100,000 of these equipment pieces placed throughout the United States.
So, for this old retired American citizen, it was nice to note that within one week I had impacted both a political election, although just the Primary, and a first-quarter financial report disclosed by my home-away-from-home’s parent company.
By the way, after my ballot was grabbed by the collection machine at the voting poll, one of the ladies at a table handed me a sticker to place on my jacket front that read: I Voted! Did You? I thanked her kindly, so she gave me one for the other front of my jacket. I kept waiting all day for someone to ask me if I had voted twice. I’m staying mum on what my answer would have been. Okay, one of my answers would have been: “No, this is not Detroit.”